Retatrutide Pens UK: A Complete Guide to All Available Formats in 2026
The market for Retatrutide pens UK has grown substantially as the compound’s Phase 2 trial results gained mainstream attention. This guide covers all available formats, how to evaluate quality, and where to buy reliably in 2026.
Available Retatrutide Pen Formats in the UK
UK suppliers currently offer Retatrutide in two primary pen formats:
- 20mg pen: Standard concentration. Most widely used format for initial and mid-range research protocols. Broadly equivalent to the VLS Retatrutide 20mg pen in format and concentration.
- 40mg pen: High-dose format. Used in extended protocols and available in bulk. The Alluvi Retatrutide 40mg pen is priced at £189.99 at alluvistore.co.uk.
What to Check on Any UK Retatrutide Pen
- Clear concentration labelling (mg per pen, not just “high dose”)
- Batch number and COA reference available
- R&D only designation clearly printed
- Manufacturer or supplier contact information present
- Tamper-evident packaging
VLS Retatrutide vs Alluvi Retatrutide Pens
VLS Retatrutide 20mg is another commonly searched UK pen format. Both VLS and Alluvi source research-grade Retatrutide pens for the UK market. The key differentiators when choosing between suppliers are: batch documentation quality, support responsiveness, UK stock availability and pricing with applicable discount codes.
When comparing Retatrutide pen suppliers, always ask for a Certificate of Analysis before ordering — a legitimate supplier will provide one without hesitation.
Ordering Retatrutide Pens from Alluvi Healthcare
Both formats are in stock at alluvistore.co.uk with UK-based inventory and 2–5 working day delivery. Use ALLUVI10 for 10% off or contact [email protected] for wholesale pricing on 5+ units.
All Formats In Stock
🛒 View all Retatrutide pen formats · ❓ 20mg vs 40mg — FAQ · 📦 My Orders
Shop Retatrutide Pens UK
20mg and 40mg formats. UK stock, batch tested, discreet delivery. ALLUVI10 for 10% off.
Shop All Pen Formats Pen Format FAQs- Retatrutide Phase 2 Trial — NEJM 2023 New England Journal of Medicine
- MHRA: Safe Purchase of Injectable Research Compounds MHRA / GOV.UK
- GLP-1 Receptor Agonist Pharmacology — Wikipedia Wikipedia
- ClinicalTrials.gov — Retatrutide Active Trials ClinicalTrials.gov